Insulet expands Omnipod 5 to Spain, raising the stakes in Europe’s insulin pump market
Read how Insulet’s Omnipod 5 Spain launch could reshape tubeless insulin delivery, reimbursement and connected diabetes care.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Insulet’s next diabetes technology challenge is not control alone, it is usability at scale
Find out how Insulet’s Omnipod 6 and fully closed-loop data could reshape automated insulin delivery for diabetes care.
Medical Devices & Diagnostics
What Insulet’s EVOLUTION 2 data means for automated insulin delivery in type 2 diabetes
Insulet's EVOLUTION 2 study shows 68% TIR with no boluses in type 2 diabetes. Analysis of what the FCL data means before the EVOLVE pivotal trial.